keyword
https://read.qxmd.com/read/38645812/the-presence-of-cribriform-pattern-in-prostate-biopsy-and-radical-prostatectomy-is-associated-with-negative-postoperative-pathological-features
#21
JOURNAL ARTICLE
Rafal Osiecki, Mieszko Kozikowski, Łukasz Białek, Michał Pyzlak, Jakub Dobruch
INTRODUCTION: Prostate cancer is the second most common male cancer worldwide. Its rising incidence and high overtreatment rate drive the search for new prognostic factors. Histopathological variants, such as cribriform pattern (CP), are associated with poorer oncologic outcome. The aim of this study was to assess the correlation between CP in prostate biopsy and radical prostatectomy (RP) and postoperative pathological features. MATERIAL AND METHODS: In this retrospective, single-centre study we analysed the reviewed medical records of 100 men who underwent minimally invasive RP in the years 2017-2019...
2024: Central European Journal of Urology
https://read.qxmd.com/read/38644292/-bioinformatics-based-analysis-of-the-effect-of-general-transcription-factor-iih-on-prognosis-of-prostate-cancer
#22
JOURNAL ARTICLE
J C Li, X J Zhu, J H Ye, Z H Tan, S H Cai, Y L Deng, J Chen, W C Tian, D H Luo, W D Zhong
Objective: To investigate the genetic and expression characteristics of transcription factor IIH (TFIIH) in pre-initiationcomplex in prostate cancer (PCa) and its relationship with prostate cancer progression. Methods: Analyzing the expression characteristics and clinical signification of TFIIH subunits about 495 cases of PCa and 52 cases of adjacent cancer in The Cancer Genome Atlas-Prostate adenocarcinoma (TCGA-PRAD) database. PCa microarray chip was used to verify the correlation between the key factor General Transcription Factor IIH Subunit 4 (GTF2H4) in TFIIH and clinical features...
April 23, 2024: Zhonghua Yi Xue za Zhi [Chinese medical journal]
https://read.qxmd.com/read/38644246/-construction-of-a-model-based-on-multipoint-full-layer-puncture-biopsy-for-predicting-pathological-complete-response-after-neoadjuvant-therapy-for-locally-advanced-rectal-cancer
#23
JOURNAL ARTICLE
Y Jin, Z W Zhai, L T Sun, P D Xia, H Hu, C Q Jiang, B C Zhao, H Qu, Q Qian, Y Dai, H W Yao, Z J Wang, J G Han
Objective: To investigate the value of transanal multipoint full-layer puncture biopsy (TMFP) in predicting pathological complete response (pCR) after neoadjuvant radiotherapy and chemotherapy (nCRT) in patients with locally advanced rectal cancer (LARC) and to establish a predictive model for providing clinical guidance regarding the treatment of LARC. Methods: In this multicenter, prospective, cohort study, we collected data on 110 LARC patients from four hospitals between April 2020 and March 2023: Beijing Chaoyang Hospital of Capital Medical University (50 patients), Beijing Friendship Hospital of Capital Medical University (41 patients), Qilu Hospital of Shandong University (16 patients), and Zhongnan Hospital of Wuhan University (three patients)...
April 25, 2024: Zhonghua Wei Chang Wai Ke za Zhi, Chinese Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/38643190/endoplasmic-reticulum-stress-related-genes-as-prognostic-and-immunogenic-biomarkers-in-prostate-cancer
#24
JOURNAL ARTICLE
Lilin Wan, Yunxia Fan, Tiange Wu, Yifan Liu, Ruixin Zhang, Saisai Chen, Chenggui Zhao, Yifeng Xue
BACKGROUND: The metastasis and aggressive nature of prostate cancer (PCa) has become a major malignancy related threat that concerns men's health. The efficacy of immune monotherapy against PCa is questionable due to its lymphocyte-suppressive nature. METHOD: Endoplasmic reticulum stress- (ERS-) and PCa-prognosis-related genes were obtained from the Molecular Signatures Database and the Cancer Genome Atlas database. The expression, prognosis and immune infiltration values of key genes were explored by "survival R package", "rms", "xCELL algorithm", and univariate-multivariate Cox and LASSO regression analyses...
April 20, 2024: European Journal of Medical Research
https://read.qxmd.com/read/38641443/site-specific-differences-of-eligibility-for-adjuvant-immunotherapy-among-urothelial-carcinoma-patients-treated-with-radical-surgery-results-from-a-multicenter-cohort-study
#25
JOURNAL ARTICLE
Chisato Narita, Fumihiko Urabe, Wataru Fukuokaya, Kosuke Iwatani, Yu Imai, Keiji Yasue, Keiichiro Mori, Koichi Aikawa, Takafumi Yanagisawa, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Yuta Yamada, Steffi Kar Kei Yuen, Jeremy Yuen-Chun Teoh, Tatsuya Shimomura, Hiroki Yamada, Akira Furuta, Jun Miki, Takahiro Kimura
BACKGROUND: The CheckMate274 trial has reported enhanced disease-free survival rates in patients with stage pT3-4/ypT2-4 or pN+ urothelial carcinoma (UC) undergoing adjuvant nivolumab therapy. This study compares prognostic differences between urothelial carcinoma of the bladder (UCB) and upper tract urothelial carcinoma (UTUC). METHODS: We retrospectively analyzed data from 719 patients with UC who underwent radical surgery, stratifying to patients at stage pT3-4 and/or pN+ without neoadjuvant chemotherapy (NAC) or at ypT2-4 and/or ypN+ with NAC (potential candidates for adjuvant immunotherapy), and to those who were not candidates for adjuvant immunotherapy...
March 21, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38639960/-application-of-artificial-intelligence-in-the-diagnosis-of-prostate-cancer
#26
JOURNAL ARTICLE
Ke-Xin Zhang, Zhan-Peng Yu, Tian-Yi Shen, Hao Tang
With the rise of precision medicine, the continuous expansionWith the rise of precision medicine, the continuous expansion the collective push from many other the application of Artificial Intelligence (AI) in prostate cancer diagnosis is increasingly becoming a focal point. AI technology can effectively utilize diverse detection methods such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and whole pathology slide imaging to efficiently identify and differentiate between benign and malignant lesions...
December 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38639952/-study-on-the-length-and-quality-of-prostate-biopsy-tissue-strips
#27
JOURNAL ARTICLE
Yin-Shuai Geng, Yong-Quan Gao, Feng-Hong Cao, Shang Wu, Xue-Fei Ding
OBJECTIVE: To improve the diagnostic yield of prostate biopsy, which we can achieve by puncture more sites and number of cores, another way to obtain more tissue is to take longer tissue strips. In this study, we evaluated the effect of strip length on cancer diagnosis by needle biopsy and derived a cutoff value of strip length to improve cancer detection. METHODS: The pathological reports of 754 patients with suspected prostate cancer who underwent transperineal prostate biopsy were retrospectively analyzed...
December 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38638689/schwann-cells-in-the-normal-and-pathological-lung-microenvironment
#28
REVIEW
Michael R Shurin, Sarah E Wheeler, Galina V Shurin, Hua Zhong, Yan Zhou
The lungs are a key organ in the respiratory system. They are regulated by a complex network of nerves that control their development, structure, function, and response to various pathological stimuli. Accumulating evidence suggests the involvement of a neural mechanism in different pathophysiological conditions in the lungs and the development and progression of common respiratory diseases. Lung diseases are the chief source of death globally. For instance, lung cancer is the second most commonly diagnosed malignancy, after prostate cancer in men and breast cancer in women, and is the most lethal cancer worldwide...
2024: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/38636170/disitamab-vedotin-alone-or-in-combination-with-immune-checkpoint-inhibitors-in-bladder-sparing-treatment-of-muscle-invasive-bladder-cancer-a-real-world-study
#29
JOURNAL ARTICLE
Anbang Wang, Ming Chen, Duocai Li, Jiazi Shi, Wenbin Tang, Zongqin Zhang, Shancheng Ren
PURPOSE: To evaluate the efficacy and safety of a novel humanized anti-HER2 antibody, RC48-ADC (Disitamab vedotin, DV), the combination of RC48-ADC with PD-1 inhibitors was used to treat muscle-invasive bladder cancer (MIBC). This combination therapy has potential applications in both bladder preservation and neoadjuvant therapy for MIBC. METHODS: Patients with MIBC underwent transurethral resection of bladder tumors followed by RC48-ADC alone or in combination with PD-1 inhibitors...
March 26, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38633832/patient-centred-pathology-reporting-improves-patient-experience-and-understanding-of-disease-in-prostate-cancer-care
#30
JOURNAL ARTICLE
Haidar Al Saffar, Alice Thomson, Jo-Lynn S Tan, Qiwei Wang, Emma Birch, Samantha Koschel, Elizabeth Medhurst, Dale Jobson, Sean Ong, Daniel A Moon, Declan Murphy, Nathan Lawrentschuk
INTRODUCTION AND OBJECTIVES: Patient-centred (PC) and holistic care improves patient satisfaction and health outcomes. We sought to investigate the benefit of utilising a PC pathology report in patients undergoing radical prostatectomy (RP) for prostate cancer (PCa). Our study aimed to evaluate and compare patient understanding of their PCa diagnosis after RP, upon receiving either a standard histopathology report or a personalised and PC report (PCR). Moreover, we evaluated knowledge retention at 4 weeks after the initial consultation...
April 2024: BJUI compass
https://read.qxmd.com/read/38633791/overexpression-of-fibroblast-activation-protein-fap-in-stroma-of-proliferative-inflammatory-atrophy-pia-and-primary-adenocarcinoma-of-the-prostate
#31
Fernanda Caramella-Pereira, Qizhi Zheng, Jessica L Hicks, Sujayita Roy, Tracy Jones, Martin Pomper, Lizamma Antony, Alan K Meeker, Srinivasan Yegnasubramanian, Angelo M De Marzo, W Nathaniel Brennen
Fibroblast activation protein (FAP) is a serine protease upregulated at sites of tissue remodeling and cancer that represents a promising therapeutic and molecular imaging target. In prostate cancer, studies of FAP expression using tissue microarrays are conflicting, such that its clinical potential is unclear. Furthermore, little is known regarding FAP expression in benign prostatic tissues. Here we demonstrated, using a novel iterative multiplex IHC assay in standard tissue sections, that FAP was nearly absent in normal regions, but was increased consistently in regions of proliferative inflammatory atrophy (PIA)...
April 5, 2024: medRxiv
https://read.qxmd.com/read/38629217/outcomes-of-10-years-of-psa-screening-for-prostate-cancer-in-norwegian-men-with-lynch-syndrome
#32
JOURNAL ARTICLE
Eli Marie Grindedal, Manuela Zucknick, Astrid Stormorken, Elin Rønne, Nora M Tandstad, William B Isaacs, Karol Axcrona, Lovise Mæhle
BACKGROUND: Pathogenic germline variants in the mismatch repair (MMR) genes are associated with an increased risk of prostate cancer (PCa). Since 2010 we have recommended MMR carriers annual PSA testing from the age of 40. Prospective studies of the outcome of long-term PSA screening are lacking. This study aimed to investigate the incidence and characteristics of PCa in Norwegian MMR carriers attending annual PSA screening (PSA threshold >3.0 ng/mL) to evaluate whether our recommendations should be continued...
April 17, 2024: Prostate
https://read.qxmd.com/read/38626660/adrenocortical-cancer-in-the-real-world-a-comprehensive-analysis-of-clinical-features-and-management-from-the-turkish-oncology-group-tog
#33
JOURNAL ARTICLE
Hatime Arzu Yasar, Burak Yasin Aktas, Gokhan Ucar, Sema Sezgin Goksu, Irem Bilgetekin, Burcu Cakar, Abdullah Sakin, Ozturk Ates, Tugba Basoglu, Cagatay Arslan, Atike Gokcen Demiray, Semra Paydas, Irfan Cicin, Mehmet Ali Nahit Sendur, Nuri Karadurmus, Hakan Kosku, Aytuğ Uner, Perran Fulden Yumuk, Gungor Utkan, Umut Kefeli, Ozgur Tanriverdi, Havva Cinkir, Ozge Gumusay, Nazım Serdal Turhal, Serkan Menekse, Engin Kut, Ismail Beypinar, Teoman Sakalar, Hacer Demir, Emre Yekeduz, Saadettin Kilickap, Mustafa Erman, Yuksel Urun
INTRODUCTION: Adrenocortical carcinoma (ACC) is a rare yet highly malignant tumor associated with significant morbidity and mortality. This study aims to delineate the clinical features, survival patterns, and treatment modalities of ACC, providing insights into the disease's prognosis. MATERIALS AND METHODS: A retrospective analysis of 157 ACC patients was performed to assess treatment methodologies, demographic patterns, pathological and clinical attributes, and laboratory results...
March 15, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38625419/prediction-of-prostate-cancer-aggressiveness-using-magnetic-resonance-imaging-radiomics-a-dual-center-study
#34
JOURNAL ARTICLE
Nini Pan, Liuyan Shi, Diliang He, Jianxin Zhao, Lianqiu Xiong, Lili Ma, Jing Li, Kai Ai, Lianping Zhao, Gang Huang
PURPOSE: The Gleason score (GS) and positive needles are crucial aggressive indicators of prostate cancer (PCa). This study aimed to investigate the usefulness of magnetic resonance imaging (MRI) radiomics models in predicting GS and positive needles of systematic biopsy in PCa. MATERIAL AND METHODS: A total of 218 patients with pathologically proven PCa were retrospectively recruited from 2 centers. Small-field-of-view high-resolution T2-weighted imaging and post-contrast delayed sequences were selected to extract radiomics features...
April 16, 2024: Discover. Oncology
https://read.qxmd.com/read/38623561/federated-attention-consistent-learning-models-for-prostate-cancer-diagnosis-and-gleason-grading
#35
JOURNAL ARTICLE
Fei Kong, Xiyue Wang, Jinxi Xiang, Sen Yang, Xinran Wang, Meng Yue, Jun Zhang, Junhan Zhao, Xiao Han, Yuhan Dong, Biyue Zhu, Fang Wang, Yueping Liu
Artificial intelligence (AI) holds significant promise in transforming medical imaging, enhancing diagnostics, and refining treatment strategies. However, the reliance on extensive multicenter datasets for training AI models poses challenges due to privacy concerns. Federated learning provides a solution by facilitating collaborative model training across multiple centers without sharing raw data. This study introduces a federated attention-consistent learning (FACL) framework to address challenges associated with large-scale pathological images and data heterogeneity...
December 2024: Computational and Structural Biotechnology Journal
https://read.qxmd.com/read/38622987/the-prevalence-and-clinical-significance-of-her2-expression-in-prostate-adenocarcinoma
#36
JOURNAL ARTICLE
Fayez Estephan, Coen J Lap, Jeff Banagan, Martha Antonio, Shanshan Liu, Guoqing Diao, Alexandra Zara Rozalen, Rithika Rajendran, Steven Krasnow, Ramesh Subrahmanyam, Victor E Nava, Maneesh Jain
AIMS: Abnormalities in HER2 are well-established oncogenic drivers and are approved therapeutic targets in various malignancies. Prior studies evaluating HER2 expression in prostate cancer (PCa) have yielded variable results. Most of these studies used immunohistochemistry scoring systems based on breast cancer data. The goal of this study was to determine the prevalence and clinical significance of HER2 expression using a scoring system that better reflects the HER2 staining pattern observed in PCa...
December 2023: Annals of Diagnostic Pathology
https://read.qxmd.com/read/38619781/clinical-features-of-prostate-cancer-by-polygenic-risk-score
#37
JOURNAL ARTICLE
Christina Spears, Menglin Xu, Abigail Shoben, Shawn Dason, Amanda Ewart Toland, Lindsey Byrne
Genome-wide association studies have identified more than 290 single nucleotide variants (SNVs) associated with prostate cancer. These SNVs can be combined to generate a Polygenic Risk Score (PRS), which estimates an individual's risk to develop prostate cancer. Identifying individuals at higher risk for prostate cancer using PRS could allow for personalized screening recommendations, improve current screening tools, and potentially result in improved survival rates, but more research is needed before incorporating them into clinical use...
April 15, 2024: Familial Cancer
https://read.qxmd.com/read/38619521/-clinical-study-of-artificial-intelligence-guided-image-fusion-assisted-transperineal-prostate-biopsy
#38
JOURNAL ARTICLE
Jun Hu, Xiao-Dong Zhao, Yu-Lin Zhou, Ning Dong, Meng-Fei Ma, Yu-Hao Chen, Zheng-Cheng Sheng, Jie Dong, Can-Qin He, Song Xu
OBJECTIVE: To compare the diagnostic efficacy of AI-guided mpMRI-TRUS fusion assisted transperineal systematic biopsy, targeted biopsy and combined biopsy in the diagnosis of PCa, and to evaluate the clinical application value of combined biopsy. METHODS: From April 2022, the general personal information and clinical data of patients with suspicious prostate lesions (PI-RADS≥3) detected by 3.0T mpMRI were collected, then underwent AI-guided mpMRI-TRUS fusion-assisted transperineal prostate biopsy...
August 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38619005/characterization-of-structural-biochemical-pharmacokinetic-and-pharmacodynamic-properties-of-the-lsd1-inhibitor-bomedemstat-in-preclinical-models
#39
JOURNAL ARTICLE
Sumer Jasmine, Adel Mandl, Timothy E G Krueger, Susan L Dalrymple, Lizamma Antony, Jennifer Dias, Cassandra A Celatka, Amy E Tapper, Maria Kleppe, Mayuko Kanayama, Yuezhou Jing, Valentina Speranzini, Yuzhuo Z Wang, Jun Luo, Bruce J Trock, Samuel R Denmeade, Michael A Carducci, Andrea Mattevi, Hugh Y Rienhoff, John T Isaacs, W Nathaniel Brennen
INTRODUCTION: Lysine-specific demethylase 1 (LSD1) is emerging as a critical mediator of tumor progression in metastatic castration-resistant prostate cancer (mCRPC). Neuroendocrine prostate cancer (NEPC) is increasingly recognized as an adaptive mechanism of resistance in mCRPC patients failing androgen receptor axis-targeted therapies. Safe and effective LSD1 inhibitors are necessary to determine antitumor response in prostate cancer models. For this reason, we characterize the LSD1 inhibitor bomedemstat to assess its clinical potential in NEPC as well as other mCRPC pathological subtypes...
April 15, 2024: Prostate
https://read.qxmd.com/read/38618206/an-artificial-intelligence-model-for-detecting-pathological-lymph-node-metastasis-in-prostate-cancer-using-whole-slide-images-a-retrospective-multicentre-diagnostic-study
#40
JOURNAL ARTICLE
Shaoxu Wu, Yun Wang, Guibin Hong, Yun Luo, Zhen Lin, Runnan Shen, Hong Zeng, Abai Xu, Peng Wu, Mingzhao Xiao, Xiaoyang Li, Peng Rao, Qishen Yang, Zhengyuan Feng, Quanhao He, Fan Jiang, Ye Xie, Chengxiao Liao, Xiaowei Huang, Rui Chen, Tianxin Lin
BACKGROUND: The pathological examination of lymph node metastasis (LNM) is crucial for treating prostate cancer (PCa). However, the limitations with naked-eye detection and pathologist workload contribute to a high missed-diagnosis rate for nodal micrometastasis. We aimed to develop an artificial intelligence (AI)-based, time-efficient, and high-precision PCa LNM detector (ProCaLNMD) and evaluate its clinical application value. METHODS: In this multicentre, retrospective, diagnostic study, consecutive patients with PCa who underwent radical prostatectomy and pelvic lymph node dissection at five centres between Sep 2, 2013 and Apr 28, 2023 were included, and histopathological slides of resected lymph nodes were collected and digitised as whole-slide images for model development and validation...
May 2024: EClinicalMedicine
keyword
keyword
95535
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.